NaviFUS (ROCO:6872) Days Payable : 0.00 (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is NaviFUS Days Payable?

NaviFUS's average Accounts Payable for the six months ended in Dec. 2023 was NT$0.00 Mil. NaviFUS's Cost of Goods Sold for the six months ended in Dec. 2023 was NT$3.70 Mil. Hence, NaviFUS's Days Payable for the six months ended in Dec. 2023 was 0.00.

The historical rank and industry rank for NaviFUS's Days Payable or its related term are showing as below:

ROCO:6872' s Days Payable Range Over the Past 10 Years
Min: 2.54 Med: 5.73 Max: 8.91
Current: 2.54

During the past 6 years, NaviFUS's highest Days Payable was 8.91. The lowest was 2.54. And the median was 5.73.

ROCO:6872's Days Payable is ranked worse than
99.59% of 724 companies
in the Biotechnology industry
Industry Median: 150.695 vs ROCO:6872: 2.54

NaviFUS's Days Payable declined from Dec. 2022 (16.37) to Dec. 2023 (0.00). It may suggest that NaviFUS accelerated paying its suppliers.

NaviFUS Days Payable Historical Data

The historical data trend for NaviFUS's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NaviFUS Days Payable Chart

NaviFUS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Payable

Get a 7-Day Free Trial

8.91

2.54

NaviFUS Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial					-	-	16.37	1.94	-

Competitive Comparison of NaviFUS's Days Payable

For the Biotechnology subindustry, NaviFUS's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NaviFUS's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NaviFUS's Days Payable distribution charts can be found below:

* The bar in red indicates where NaviFUS's Days Payable falls into.

NaviFUS Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

NaviFUS's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

	Days Payable (A: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Dec. 2022 )	+	Accounts Payable (A: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (A: Dec. 2023 )	*	Days in Period
=	( (0.074	+	0)	/	1 )	/	10.654	*	365
=	0.074					/	10.654	*	365
=	2.54

NaviFUS's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (0	+	0)	/	1 )	/	3.702	*	365 / 2
=	0					/	3.702	*	365 / 2
=	0.00

NaviFUS Days Payable Related Terms

Thank you for viewing the detailed overview of NaviFUS's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

NaviFUS (ROCO:6872) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NaviFUS Corp (ROCO:6872) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.246, Sec 3, Chengde Road, 12th Floor, Datong District, Taipei City, TWN, 103

Website

https://www.navifus.com

NaviFUS Corp is a Biotech company providing novel platform solutions for crossing the blood-brain barrier (BBB) for enhanced oncology drug delivery. Its product, the NaviFUS System, is designed to utilize non-invasive ultrasound energy to enable transient and safe enhancement of BBB permeability to facilitate the transport of small or large molecular CNS drugs to target tumor tissue at high precision for better treatment outcomes. Its vision is to cater to CNS disease patients locally and globally by bringing therapeutic ultrasound technology to clinical use.

NaviFUS (ROCO:6872) Headlines

No Headlines